Evidence map›Paper›PMID 38983197›Full record

ArticlePeerJ. Computer science2024

Multi level perspectives in stock price forecasting: ICE2DE-MDL.

Zinnet Duygu Akşehir, Erdal Kılıç

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zinnet Duygu AkşehirComputer Engineering, Ondokuz Mayis University Samsun, Samsun, Turkey.
Erdal KılıçComputer Engineering, Ondokuz Mayis University Samsun, Samsun, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study proposes a novel hybrid model, called ICE2DE-MDL, integrating secondary decomposition, entropy, machine and deep learning methods to predict a stock closing price. In this context, first of all, the noise contained in the financial time series was eliminated. A denoising method, which utilizes entropy and the two-level ICEEMDAN methodology, is suggested to achieve this. Subsequently, we applied many deep learning and machine learning methods, including long-short term memory (LSTM), LSTM-BN, gated recurrent unit (GRU), and SVR, to the IMFs obtained from the decomposition, classifying them as noiseless. Afterward, the best training method was determined for each IMF. Finally, the proposed model's forecast was obtained by hierarchically combining the prediction results of each IMF. The ICE2DE-MDL model was applied to eight stock market indices and three stock data sets, and the next day's closing price of these stock items was predicted. The results indicate that RMSE values ranged from 0.031 to 0.244, MAE values ranged from 0.026 to 0.144, MAPE values ranged from 0.128 to 0.594, and R-squared values ranged from 0.905 to 0.998 for stock indices and stock forecasts. Furthermore, comparisons were made with various hybrid models proposed within the scope of stock forecasting to evaluate the performance of the ICE2DE-MDL model. Upon comparison, The ICE2DE-MDL model demonstrated superior performance relative to existing models in the literature for both forecasting stock market indices and individual stocks. Additionally, to our knowledge, this study is the first to effectively eliminate noise in stock item data using the concepts of entropy and ICEEMDAN. It is also the second study to apply ICEEMDAN to a financial time series prediction problem.

Indexed as

Deep learningDenoising approachFinancial time seriesICEEMDANMode decompositionStock price prediction

Identifiers

PMID38983197
PMCPMC11232590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.